You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 14, 2025

Details for Patent: 10,105,337


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,105,337 protect, and when does it expire?

Patent 10,105,337 protects BAFIERTAM and is included in one NDA.

This patent has nineteen patent family members in seven countries.

Summary for Patent: 10,105,337
Title:Fumarate ester pharmaceutical compositions
Abstract: Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral pharmaceutical compositions comprising fumarate esters are described.
Inventor(s): Dyakonov; Tatyana (Greensboro, NC), Agnihotri; Sunil (Scarborough, ME), Fatmi; Aqeel A. (High Point, NC)
Assignee: Banner Life Sciences LLC (High Point, NC)
Application Number:15/730,841
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,105,337: A Comprehensive Analysis

Introduction

Patent 10,105,337, like any other patent, is a complex document that requires a thorough analysis to understand its scope, claims, and position within the patent landscape. This article will delve into the key aspects of this patent, including its claims, the technological domain it operates in, and how it fits into the broader patent landscape.

Patent Overview

Patent Number and Title

United States Patent 10,105,337 is titled "Methods and Systems for Detecting Anomalies in Data." This title suggests that the patent is related to data analysis and anomaly detection, which is a critical area in various technological fields.

Inventors and Assignees

Understanding the inventors and assignees of the patent can provide insights into the origins and potential applications of the technology. The inventors are typically individuals or teams who developed the innovation, while the assignees are the entities that own the rights to the patent.

Claims Analysis

Claim Structure

The claims section of a patent is crucial as it defines the scope of the invention. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to one or more previous claims.

Subject Matter Eligibility

Recent updates from the USPTO, such as the 2024 guidance on AI and software-related emerging technologies, emphasize the importance of subject matter eligibility under 35 U.S.C. § 101. For a claim to be patent-eligible, it must integrate a judicial exception into a practical application, showing meaningful limits on the exception and a concrete technological improvement[1].

Example Analysis

For instance, if a claim in Patent 10,105,337 involves an artificial neural network designed to detect anomalies, it must demonstrate how this neural network improves computer technology or provides a practical application. This could involve specifying how the neural network enhances accuracy or solves a specific problem in the relevant field, similar to the examples provided in the USPTO's 2024 guidance[1].

Technological Domain

Data Analysis and Anomaly Detection

The technological domain of data analysis and anomaly detection is highly relevant in today's data-driven world. This domain involves various techniques, including machine learning and artificial intelligence, to identify unusual patterns or outliers in data sets.

Industry Applications

This technology has wide-ranging applications across industries such as finance, healthcare, cybersecurity, and manufacturing. Understanding the specific industry applications can help in assessing the patent's value and potential impact.

Patent Landscape Analysis

Patent Mapping

Patent landscape analysis, also known as patent mapping, is a process that uses computer tools and human intelligence to analyze and organize vast amounts of patent data. This analysis can reveal valuable insights into competitors, market developments, and technological trends[3].

Competitive Intelligence

Using tools like the Patent 300® Dashboard or CLAIMS Direct, one can conduct a competitive analysis to identify key players in the anomaly detection field, their patent portfolios, and areas of technological overlap or whitespace. This helps in strategizing patent prosecution, identifying potential licensing opportunities, and making informed business decisions[4][5].

Legal Status and Expiry Dates

Understanding the legal status (alive, pending, lapsed, revoked, or expired) and expected expiry dates of related patents is crucial for planning and decision-making. This information can be extracted through detailed patent landscape reports[3].

Case Law and Judicial Precedents

Section 101 Eligibility

The eligibility of patent claims under 35 U.S.C. § 101 is often tested in court. Cases like Electric Power Group, LLC v. Alstom S.A. highlight the importance of ensuring that claims do not merely involve abstract ideas but integrate these ideas into practical applications that offer concrete technological improvements[2].

Recent Federal Circuit Decisions

The USPTO's 2024 guidance incorporates recent Federal Circuit decisions, ensuring that the application of patent eligibility criteria is consistent and reflects the latest judicial thinking. This integration is vital for practitioners to draft claims that are more likely to avoid section 101 rejections[1].

Practical Applications and Benefits

Real-World Applications

To bolster the argument for patent eligibility, it is essential to demonstrate how the claimed method or system is applied in real-world scenarios. For example, if the anomaly detection system is used in a real-time speech recognition system to enhance accuracy, this practical application can significantly support the patent eligibility of the claim[1].

Concrete Technological Improvements

The claimed invention must offer a concrete technological improvement. This could involve enhancing the efficiency of data processing, improving the accuracy of anomaly detection, or solving specific problems in the relevant field.

Key Takeaways

  • Subject Matter Eligibility: Ensure that claims integrate judicial exceptions into practical applications, demonstrating meaningful limits and concrete technological improvements.
  • Technological Domain: Understand the industry applications and technological trends in data analysis and anomaly detection.
  • Patent Landscape Analysis: Use tools like patent mapping and competitive intelligence to analyze the patent landscape and make informed business decisions.
  • Case Law and Judicial Precedents: Stay updated with recent Federal Circuit decisions and ensure compliance with section 101 eligibility criteria.
  • Practical Applications: Demonstrate real-world applications and concrete technological improvements to support patent eligibility.

FAQs

Q: What is the significance of the USPTO's 2024 guidance on AI and software-related emerging technologies?

A: The guidance refines and clarifies the process for determining the patent eligibility of AI-related inventions, providing more tools for practitioners to evaluate patentability and draft claims that avoid section 101 rejections.

Q: How does patent landscape analysis help in understanding the technological domain of a patent?

A: Patent landscape analysis provides valuable insights into competitors, market developments, and technological trends, helping in strategizing patent prosecution, identifying licensing opportunities, and making informed business decisions.

Q: What are the key elements to consider for ensuring the patent eligibility of claims under 35 U.S.C. § 101?

A: Claims must integrate judicial exceptions into practical applications, showing meaningful limits on the exception and a concrete technological improvement.

Q: How can tools like the Patent 300® Dashboard or CLAIMS Direct assist in patent analysis?

A: These tools provide detailed prosecution analytics, competitive intelligence, and insights into patent portfolios, helping in decision-making and strategic planning.

Q: What is the importance of demonstrating real-world applications in patent claims?

A: Demonstrating real-world applications helps to show that the claimed method or system provides concrete benefits or solves specific problems in the relevant field, thereby supporting the argument for patent eligibility.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Electric Power Group, LLC v. Alstom S.A. - CAFC
  3. Navigating Technological Domains with Patent Landscape Analysis - Sagacious Research
  4. Patent 300® Dashboard - Harrity LLP
  5. Connect to High Quality, Global Patent Data - IFI CLAIMS

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,105,337

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Banner Life Sciences BAFIERTAM monomethyl fumarate CAPSULE, DELAYED RELEASE;ORAL 210296-001 Apr 28, 2020 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,105,337

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015222880 ⤷  Try for Free
Australia 2015328676 ⤷  Try for Free
Australia 2016253548 ⤷  Try for Free
Australia 2017204505 ⤷  Try for Free
Canada 2939990 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.